Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000320017-24-000017
Filing Date
2024-04-29
Accepted
2024-04-29 16:53:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14anotice20240429.htm DEFA14A 11656
2 finalproxynoticeapril23_pa.jpg GRAPHIC 498397
3 finalproxynoticeapril23_paa.jpg GRAPHIC 558117
  Complete submission text file 0000320017-24-000017.txt   1467637
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33650 | Film No.: 24892129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)